Topics under consideration under the IMI programme Combating Antibiotic Resistance: New Drugs for Bad Bugs (ND4BB)*
- Topic 1C: Innovative Trial Design & Clinical Development (work package 6 of Topic 1)
- Topic 3: Discovery and development of new drugs combating Gram – negative infections
*ND4BB (‘New Drugs for Bad Bugs’) represents a core element of the Action plan against the rising threats from Antimicrobial Resistance adopted by the European Commission as an answer to the Council Conclusions and the European Parliament resolution to establish an EU-wide plan to combat antimicrobial resistance. The ND4BB programme started in IMI’s 6th Call launched in May 2012 with two topics, and further topics are under consideration.
Other topics under consideration
- Developing an aetiology-based taxonomy of human disease
- European induced pluripotent stem cell bank
All information regarding future IMI Call topics is indicative and subject to change. Final information about IMI’s future Calls will be communicated after approval by the IMI Governing Board.